Dr. Mark Davis, discoverer of the first T-cell receptor genes and Stanford Professor, to advise the Company on immunological strategies for its novel cancer treatment platformLehi Utah, Jan. 07, 2026 ...

In A Nutshell Three Brazilian supercentenarians survived COVID-19 in 2020 before vaccines existed, showing remarkably strong ...

A Viewpoint published in Genomic Psychiatry examines how Brazil's extraordinary genetic diversity creates unparalleled ...

An elevated neutrophil-to-lymphocyte ratio (NLR) is significantly associated with increased risk of depressive disorder (DD) ...

IT’S something we all do lots of this time of year – dismiss symptoms as ‘nothing to worry about’ or just a ‘bug’. But when ...

Medically reviewed by Amelia MacIntyre, DO Key Takeaways Vitamin C can boost your immune system by stimulating white blood ...

Some cancers may not require immediate treatment, from prostate cancer to thyroid tumors. Medical experts share when ...

Kathy Dong, PharmD, MBA, President and CEO of Electra Therapeutics, will present an overview of the company and its portfolio of first-in-class SIRP-targeted therapies. Presentation Details: Date: ...

Melanoma cancer cells can paralyze the immune cells that attack them by secreting extracellular vesicles, a new study finds.

Iovance Biotherapeutics Inc. (NASDAQ:IOVA) is one of the best biotech penny stocks to buy according to analysts.